Open Label Prolonged-Use of Inhaled Gaseous Nitric Oxide (gNO) for a Single Adult With Non-Tuberculous Mycobacteria Infection
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2018
At a glance
- Drugs Nitric oxide (Primary)
- Indications Mycobacterial infections
- Focus Therapeutic Use
- 02 Oct 2018 Planned End Date changed from 19 Aug 2018 to 1 Mar 2019.
- 02 Oct 2018 Planned primary completion date changed from 19 Jun 2018 to 31 Dec 2018.
- 20 Mar 2018 Status changed from planning to recruiting.